CASIN and AMD3100 enhance endothelial cell proliferation, tube formation and sprouting

Area of Science:

• Biomedical Engineering
• Cell Biology
• Vascular Biology

Background:

• Endothelial dysfunction is a key factor in cardiovascular diseases, necessitating improved methods for generating vascular-forming cells.
• Current tissue-engineered vein approaches require large numbers of endothelial cells, limiting clinical application.
• Hematopoietic and endothelial cells share developmental origins, suggesting similar regulatory mechanisms.

Purpose of the Study:

• To investigate the potential of small molecules, previously shown to expand hematopoietic stem cells, to induce endothelial cell expansion and angiogenesis.
• To identify specific small molecules that can accelerate the expansion of vascular-forming cells for therapeutic applications.

Main Methods:

• Screening of thirty-five small molecules for their effect on endothelial cell expansion and function.
• Assessment of endothelial cell migration, apoptosis, and cell cycle regulation.
• Analysis of key endothelial marker gene expression and cyclin-dependent kinase inhibitors.

Main Results:

• CASIN and AMD3100 were identified as small molecules that increase endothelial cell expansion up to two-fold.
• These compounds also promoted tube formation and ex vivo sprouting of endothelial cells.
• CASIN and AMD3100 modulated endothelial cell cycle, migration, and apoptosis, upregulating endothelial markers and downregulating cell cycle inhibitors.

Conclusions:

• CASIN and AMD3100 show promise for enhancing endothelial cell expansion and angiogenesis.
• These molecules could be valuable in developing artificial vascular systems and vascular gene editing technologies.
• The findings suggest potential therapeutic applications for diseases involving endothelial damage.